期刊
SEMINARS IN ONCOLOGY
卷 50, 期 3-5, 页码 86-89出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.seminoncol.2023.06.001
关键词
NTRK fusion cancer; Comprehensive geriatric assessment; Tyrosine kinase inhibitor; Clinical trials; Older people